Inventaire - prietenii tai și comunicațiile sunt cea mai buna librărie

Imidazoquinoxaline anticancer derivatives and imiquimod interact with tubulin: Characterization of molecular microtubule inhibiting mechanisms in correlation with cytotoxicity.

autor

Alexis Courbet

1987 -

Martine Pugniere

Sonia Khier

publicat în: PLOS One

Data de publicare: 2017-08-10

Limbă: limba engleză

Citează articole 53

Dată

Title

Autori

2016-04-01

New imidazoquinoxaline derivatives: Synthesis, biological evaluation on melanoma, effect on tubulin polymerization and structure-activity relationships

Jean-François Guichou, Kamel Hadj-Kaddour, Laure-Anaïs Vincent, Pierre Cuq, Pierre-Antoine Bonnet
2014-04-21

Imiquimod inhibits melanoma development by promoting pDC cytotoxic functions and impeding tumor vascularization

Caroline Aspord, Julie Charles
2014-04-17

The novel microtubule-destabilizing drug BAL27862 binds to the colchicine site of tubulin with distinct effects on microtubule organization

Michel O Steinmetz
2014-07-01

EAPB0503, a novel imidazoquinoxaline derivative, inhibits growth and induces apoptosis in chronic myeloid leukemia cells

Pierre-Antoine Bonnet, Ali Bazarbachi, Nasr Rihab, Ahmad Iskandarani, Rabab El Eit
2014-03-31

Toll-like receptors and skin cancer
2014-08-01

Anti-tubulins DEPendably induce apoptosis
2013-04-16

In vitro and in vivo growth inhibition of prostate cancer by the small molecule imiquimod
2013-01-01

Clearance of invasive melanoma with topical imiquimod
2013-06-10

Trial Watch: Toll-like receptor agonists for cancer therapy

Guido Kroemer, Laurence Zitvogel, Catherine Sautès-Fridman, Alexander Eggermont, Erika Vacchelli, Jérôme Galon, Lorenzo Galluzzi
2012-07-20

An overview of tubulin inhibitors that interact with the colchicine binding site
2012-01-01

Imiquimod 5% cream use in dermatology, side effects and recent patents

Stefano Calvieri
2012-06-27

Treatment patterns and outcomes among patients diagnosed with unresectable stage III or IV melanoma in Europe: a retrospective, longitudinal survey (MELODY study).

Paul Lorigan, Michele Maio, Paolo Antonio Ascierto
2011-10-12

The tubulin colchicine domain: a molecular modeling perspective

Alberto Massarotti, Romano Silvestri, Andrea Brancale
2011-08-18

Immunomodulation by imiquimod in patients with high-risk primary melanoma

Antoni Ribas
2011-07-13

Topical treatment of cutaneous metastases of malignant melanoma using combined imiquimod and 5-fluorouracil
2010-01-15

Drug combination studies and their synergy quantification using the Chou-Talalay method
2010-01-30

AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading
2010-07-21

Metabolism and pharmacokinetics of EAPB0203 and EAPB0503, two imidazoquinoxaline compounds previously shown to have antitumoral activity on melanoma and T-lymphomas

Sonia Khier, Pierre-Antoine Bonnet
2009-05-01

Beyond a decade of 5% imiquimod topical therapy
2009

S9, a novel anticancer agent, exerts its anti-proliferative activity by interfering with both PI3K-Akt-mTOR signaling and microtubule cytoskeleton

Xu-Rui Shen
2009-02-21

New imidazo[1,2-a]quinoxaline derivatives: synthesis and in vitro activity against human melanoma
2009-05-01

Endogenous Noxa Determines the Strong Proapoptotic Synergism of the BH3-Mimetic ABT-737 with Chemotherapeutic Agents in Human Melanoma Cells

Christian Ploner
2009-05-01

Quantitation of imidazo[1,2-a]quinoxaline derivatives in human and rat plasma using LC/ESI-MS

Sonia Khier, Pierre-Antoine Bonnet
2008-05-10

In vitro and in vivo anti-tumoral activities of imidazo[1,2-a]quinoxaline, imidazo[1,5-a]quinoxaline, and pyrazolo[1,5-a]quinoxaline derivatives

Pierre-Antoine Bonnet
2008-01-24

EAPB0203, a member of the imidazoquinoxaline family, inhibits growth and induces caspase-dependent apoptosis in T-cell lymphomas and HTLV-I-associated adult T-cell leukemia/lymphoma

Olivier Hermine, Yves Lepelletier, Pierre-Antoine Bonnet, Ali Bazarbachi, Youmna Kfoury, Marwan El Sabban, Hiba El Hajj
2007-12

Imiquimod: mode of action
2007-02-01

Phase I/II study of topical imiquimod and intralesional interleukin-2 in the treatment of accessible metastases in malignant melanoma.
2006-07-01

Impairment of TNF-alpha production and action by imidazo[1,2- alpha] quinoxalines, a derivative family which displays potential anti-inflammatory properties
2006-09

Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies
2006-02-01

New arylthioindoles: potent inhibitors of tubulin polymerization. 2. Structure-activity relationships and molecular modeling studies

Gabriela Chiosis, Giuseppe La Regina, Romano Silvestri, Andrea Brancale
2006-12-17

Kinetic analysis of tubulin assembly in the presence of the microtubule-associated protein TOGp
2005-01-01

ZINC--a free database of commercially available compounds for virtual screening

John J Irwin, Brian K. Shoichet

Articol - wd:Q41349651

Bun Venit la Inventaire!

the library of your friends and communities

afla mai multe